In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...
TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...
The Board declared a quarterly dividend of $0.125 per share, payable on April 3, 2025 to shareholders of record on March 12, 2025.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Becton Dickinson (BDX – Research Report), Idexx Laboratories ...
K92 Mining Inc. ("K92" or the "Company") announces that it will release its 2024 fourth quarter financial results before the North American trading markets open on Monday, March 17, 2025. Conference ...
Cencora COR is slated to report first-quarter fiscal 2025 results on Feb. 05, before market open. In the last reported ...